Trial record 2 of 16 for:    Avanir

Efficacy, Safety, and Tolerability Study of AVP-786 as an Adjunctive Therapy in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified May 2014 by Avanir Pharmaceuticals
Sponsor:
Information provided by (Responsible Party):
Avanir Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT02153502
First received: May 29, 2014
Last updated: May 30, 2014
Last verified: May 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: July 2017
  Estimated Primary Completion Date: February 2017 (Final data collection date for primary outcome measure)